Eagle Pharmaceuticals Cash from Investing (TTM) Trends

Eagle Pharmaceuticals Inc (EGRX)

4.70 +0.13 (+2.84%) USD | NASDAQ | Apr 23, 10:42

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2023	-23.81M
March 31, 2023	-99.22M
December 31, 2022	-86.83M
September 30, 2022	-86.87M
June 30, 2022	-75.64M
March 31, 2022	-0.107M
December 31, 2021	-5.323M
September 30, 2021	-5.444M
June 30, 2021	-5.64M
March 31, 2021	-5.659M
December 31, 2020	-18.25M
September 30, 2020	-18.21M
June 30, 2020	-18.31M
March 31, 2020	-18.57M
December 31, 2019	-0.777M
September 30, 2019	-0.728M
June 30, 2019	-0.457M
March 31, 2019	-0.291M
December 31, 2018	-0.133M
September 30, 2018	-2.782M

Date	Value
June 30, 2018	-4.321M
March 31, 2018	-4.529M
December 31, 2017	-5.186M
September 30, 2017	-30.07M
June 30, 2017	-42.68M
March 31, 2017	-42.57M
December 31, 2016	-45.80M
September 30, 2016	5.334M
June 30, 2016	84.44M
March 31, 2016	10.26M
December 31, 2015	-1.881M
September 30, 2015	-5.41M
June 30, 2015	-90.34M
March 31, 2015	-16.06M
December 31, 2014	-0.05M
September 30, 2014	-20.04M
June 30, 2014	-0.0491M
March 31, 2014	-0.0756M
December 31, 2013	-0.048M
September 30, 2013	1.459M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-99.22M

Minimum

Mar 2023

-0.107M

Maximum

Mar 2022

-27.64M

Average

-18.21M

Median

Sep 2020

Cash from Investing (TTM) Benchmarks